
The agenda for Fundamentals in Government Programs and Pricing started off with the overview of the "Current Government Pricing Landscape," by John Shakow, Partner, King & Spalding. This session was a nice overview on what drug manufacturers must do to comply with the different government program regulations and guidance. In addition to the other sessions already mentioned, attendees heard more about the differences between branded and generic products, Medicaid Supplemental Contracts, and , and what “compliance” means within the GP arena. Throughout the workshop, industry representatives provided their perspective on managing a GP department and the amount operational resources that should be taken in consideration.
The workshop also touched on the much anticipated Final Rule, expected to be released May 2014, and how manufacturers will be challenged to implement and comply with the changes. Presenters John Shakow and Miree Lee expressed their thoughts that once the CMS publishes the Final Rule, manufacturers will have approximately three to six months to implement the changes and that CMS might even include a staggered implementation.
Stay tuned tomorrow for there is another packed day full of great information.
No comments:
Post a Comment